This test is most useful if any of these apply to you.
If you eat a lot of grain-based foods, or you work around grain dust, this test can show whether a poison made by common crop molds has recently made it into your body. Most people never think to look, because nothing on a routine physical or blood panel checks for it.
This is a research-stage exposure marker, not a diagnosis. It captures recent intake rather than long-term buildup, and there is no agreed-upon number that separates safe from unsafe.
The test measures T-2 (T-2 toxin), one of a family of poisons called trichothecenes that are produced by Fusarium, a group of molds that infect cereal crops. These molds grow on barley, wheat, maize, rice, oats, and animal feed, both in the field and during storage. T-2 is not something your body makes. A positive urine result means the toxin got into you from an outside source, usually contaminated food.
One detail matters for how you read your result. Once T-2 enters the body, the liver rapidly converts most of it into a closely related product called HT-2 (a breakdown product of T-2). Because of this, HT-2 is often the more abundant and more informative marker in urine, and human studies increasingly measure T-2 together with its metabolites and their bound (conjugated) forms rather than parent T-2 alone. A test that measures only parent T-2 can badly understate your true exposure.
T-2 is absorbed quickly, broken down in the liver, and cleared into urine and stool within a short window. That means a urine reading reflects what you took in over roughly the last day, not a lifetime of accumulation. Recent human research helps pin down the timing: after ingestion, most of the dose is excreted as HT-2 within about half a day, and the toxin clears with a rapid half-life of only a few hours. Human studies have now started to model how much of an absorbed dose reaches urine, with one 2025 estimate of roughly 18%, but these figures are still preliminary and not reliable enough to back-calculate an exact intake from a single concentration.
In practice, urinary T-2 is used as a snapshot of recent internal exposure. It tells you the toxin reached your bloodstream, which food testing or a diet diary cannot confirm, because those only describe what was in the environment, not what your body actually absorbed.
Across human biomonitoring studies, T-2 turns up less often than better-known grain toxins, and usually at low levels. In French grain elevator workers, urinary T-2 was found in about 4% of samples. In a study of about 200 Japanese adults, 26% had detectable combined T-2/HT-2. In a group of UK children, combined T-2/HT-2 was detected far more often, in about 60% of samples.
These detection rates are not directly comparable. Studies differ in whether they measured parent T-2 alone or combined T-2/HT-2, and in whether samples were chemically treated to release the bound (conjugated) forms before analysis. In some recent work, free T-2 and HT-2 were not detected at all until this deconjugation step, after which HT-2 appeared in almost every sample. Diet, location, and assay method all shape the numbers, so a single result should be read as one data point about recent exposure rather than a fixed feature of your health.
A small pilot study in northeastern Iran compared urine from people with esophageal cancer against healthy controls. T-2 was detected only in the cancer group, in about 5.8% of those samples, at a creatinine-adjusted level of 44.70 micrograms per gram (a way of correcting for how dilute the urine was). This is an early signal, not proof. The study was tiny, could not establish cause and effect, and the authors called explicitly for further investigation. Treat any link between urinary T-2 and esophageal cancer as unconfirmed.
In parts of Tibet, China, an epidemiologic investigation reported that higher T-2 content in brick tea tracked with the occurrence of Kashin-Beck disease, a bone and joint disorder seen in specific endemic regions. This is background on a suspected environmental exposure source, not evidence from urinary biomarker studies. It does not show that a urinary T-2 level predicts joint disease, and it is included here only to explain why T-2 has drawn attention as a possible contributor in those regions.
T-2 is genuinely toxic at the cellular level. It blocks the machinery cells use to build proteins and disrupts how cells generate energy, which hits fast-dividing tissues hardest. Most of the detailed damage evidence, covering the liver, kidneys, immune system, gut lining, and nervous system, comes from animal and laboratory studies rather than from human urine measurements. That research explains why the toxin matters, but it has not been connected to any specific urine level in people. No human urine concentration in the current literature predicts when symptoms will begin.
Because T-2 reflects recent exposure and clears quickly, a single sample is a poor guide to your typical exposure. Repeated-sampling studies of mycotoxins found that many people who tested positive at one time point were negative at another, and concentrations often varied substantially between collections. Whether you provided a spot sample or a full 24-hour collection, and the time of day, can also shift the result.
There are no standardized clinical cutpoints and no validated schedule for repeat testing. In a research setting or a structured exposure investigation, repeated sampling can help tell a one-off spike apart from ongoing exposure. If your goal is to see whether cutting back on grain-based foods lowers your reading, more than one measurement is the only way to check, but no guideline establishes how often to repeat the test, and serial testing has not been validated as clinical care.
If T-2 shows up when you did not expect it, the next move is to widen the picture rather than react to the single number. Ask whether the assay also measured HT-2 and other mold toxins, since T-2 rarely appears alone and co-exposure with toxins like deoxynivalenol, zearalenone, and ochratoxin A is common. A broader multi-toxin urine panel can put your result in context as exposure assessment and help suggest whether grain-based foods, a specific product, or a workplace is the likely source. This is contextual exposure information, not a test that guides standard medical treatment.
From there, the practical path is to look for the source, adjust or test suspect foods, and repeat the measurement if you want to see whether the level falls. A persistently positive result, or one paired with unexplained symptoms or a known heavy occupational exposure, is worth reviewing with a clinician or medical toxicologist who can weigh timing, diet, and assay quality. The current science does not support diagnosing any disease from a T-2 urine result on its own.
Evidence-backed interventions that affect your T2 level
T-2 Toxin is best interpreted alongside these tests.
T-2 Toxin is included in these pre-built panels.